Human placental lactogen (hPL), also known as human chorionic somatomammotropin, is a hormone produced by the syncytiotrophoblast. Its primary role is to stimulate maternal lipolysis and insulin resistance. This shunts carbohydrates (glucose) towards the fetus while promoting the use of free fatty acids for maternal energy, ensuring the fetus has a constant supply of nutrients.

The ductus venosus is a key shunt in fetal circulation. It allows approximately half of the oxygenated blood returning from the placenta via the umbilical vein to bypass the fetal liver sinusoids and flow directly into the inferior vena cava, mixing with deoxygenated blood from the lower body before entering the right atrium.

Sertoli cells are the 'nurse' cells of the seminiferous tubules. They form tight junctions with each other, creating the blood-testis barrier. They also nourish developing sperm cells, phagocytize residual bodies, and secrete inhibin B and androgen-binding protein. Dysfunction of Sertoli cells would disrupt this supportive environment and impair spermatogenesis.

Human chorionic gonadotropin (hCG) is a peptide hormone produced by the syncytiotrophoblast of the developing placenta shortly after implantation. It acts as an LH analog, 'rescuing' the corpus luteum from degradation and stimulating it to continue producing progesterone, which is essential for maintaining the endometrium until the placenta can take over this function around 8-10 weeks of gestation.

While testosterone, secreted by fetal Leydig cells, mediates the development of the internal male ductal system (Wolffian ducts), the development of the external male genitalia (penis, scrotum) and prostate requires the conversion of testosterone to the more potent androgen, dihydrotestosterone (DHT), by the enzyme 5-alpha-reductase.

The milk let-down reflex is a neurohormonal reflex. Suckling by the infant sends afferent signals to the hypothalamus, which triggers the pulsatile release of oxytocin from the posterior pituitary. Oxytocin travels to the breast and causes contraction of the myoepithelial cells surrounding the alveoli and ducts, ejecting the milk.

The secretory phase (days 14-28) is dominated by progesterone produced by the corpus luteum. Progesterone acts on the estrogen-primed endometrium, causing the glands to become dilated, coiled (tortuous or 'corkscrew' in appearance), and to secrete glycogen-rich mucus. The stroma becomes edematous and spiral arteries elongate. These changes prepare the endometrium for implantation.

Oogenesis begins in fetal life. All oogonia enter meiosis I and become primary oocytes before birth. These primary oocytes are then arrested in prophase of meiosis I (specifically, the diplotene stage) and remain in this state until puberty. After puberty, a small number of oocytes resume meiosis I with each menstrual cycle.

At birth, the infant's first breath expands the lungs, causing a dramatic decrease in pulmonary vascular resistance. This allows a large volume of blood to flow to the lungs, which then returns to the left atrium. The increased blood return raises the pressure in the left atrium above the pressure in the right atrium. This pressure differential pushes the flap-like septum primum against the septum secundum, functionally closing the foramen ovale.

This patient has androgen insensitivity syndrome. The 46,XY karyotype leads to the development of testes, which correctly produce both testosterone and anti-Müllerian hormone (AMH), also known as Müllerian-inhibiting substance. AMH, secreted by Sertoli cells, causes the regression of the Müllerian ducts, which would have become the fallopian tubes, uterus, and upper vagina. The lack of response to testosterone and DHT explains the female external phenotype and lack of Wolffian duct development.